Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double

L Hu1, L S M Boesten, P May

  • 1Vascular Medicine Unit, Department of General Internal Medicine, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.

Abstract

Insights

Macrophage low-density lipoprotein receptor (LDLR)-related protein (LRP) deficiency worsens atherosclerosis in vivo. Absence of LRP in macrophages promotes advanced lesions with more collagen and fewer T cells, suggesting an atheroprotective role.

Area of Science:

  • Cardiovascular biology
  • Atherosclerosis research
  • Macrophage biology

Background:

  • In vitro studies suggest macrophage LDLR-related protein (LRP) is pro-atherogenic.
  • The in vivo role of macrophage LRP in atherogenesis, independent of lipoprotein uptake, remains unclear.

Purpose of the Study:

  • To investigate the in vivo role of macrophage-specific LRP in atherogenesis.
  • To determine if macrophage LRP influences lesion development independent of lipoprotein metabolism.

Main Methods:

  • Generated macrophage-specific LRP-deficient mice on an apoE/LDLR double-deficient background.
  • Analyzed atherosclerotic lesion area, composition (macrophages, smooth muscle cells, collagen), and immune cell infiltration (T cells) in aortic roots.

Main Results:

  • Macrophage LRP deficiency did not alter plasma lipid levels or lipoprotein distribution.
  • Lesions in LRP-deficient mice showed a 1.8-fold increase in total area and a higher proportion of advanced lesions.
  • Lesions exhibited increased collagen content (1.7-fold) and decreased CD3+ T cells (2.3-fold reduction).

Conclusions:

  • Macrophage LRP plays an atheroprotective role in vivo, independent of lipoprotein uptake.
  • Absence of macrophage LRP promotes more advanced atherosclerosis with altered extracellular matrix composition.
  • Macrophage LRP may modulate the atherosclerotic microenvironment, influencing collagen deposition and T cell infiltration.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...